All of the following are poor prognostic markers of multiple myeloma, except:
Several cytogenetic abnormalities such as t(4;14), del(17/17p), t(14;16), t(14;20), nonhyperdiploidy, and gain(1q) are identified that confer poor prognosis in cases of multiple myeloma.
t(1;14)
t(14;16)
1q gain
t(14;20)
JIPMER 2019